Stocktoria

ADAPTIN BIO, INC. APTN

OTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2026-03-17

ADAPTIN BIO, INC. (APTN) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend.

3/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

How it ranks in Manufacturing · percentile among 1906 companies

Piotroski Fstronger than 27%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 3/9 tests passed

Sector peers · similar-size Manufacturing companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
APTNADAPTIN BIO, INC.3/9
AMGNAMGEN INC6/90.1425.1+10%
GILDGILEAD SCIENCES, INC.7/93.2818.7+2.4%
BIIBBIOGEN INC.4/924.7+2.2%
NBIXNEUROCRINE BIOSCIENCES INC5/96.2135.4+21.4%
EXELEXELIXIS, INC.6/97.6917.6+7%
QGENQIAGEN N.V.7/95.0619.1+5.7%

All Manufacturing companies →

FAQ

Is APTN financially healthy?

ADAPTIN BIO, INC.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).

Does APTN pay a dividend?

No, ADAPTIN BIO, INC. does not currently pay a dividend.

Source: SEC EDGAR filings · CIK 0001938571 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.